首页 > 最新文献

AME Case Reports最新文献

英文 中文
Improved percutaneous transtracheal ventilation for airway obstruction in tongue cancer: a case report. 改良经皮气管通气治疗舌癌气道阻塞1例。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-101
Liangyu Zheng, Youfa Zhou, Dachun Zhou

Background: Patients with advanced-stage tongue cancer are often confronted with an increased risk of difficult airway management due to anatomical changes caused by prior surgeries and radiation therapy. These alterations may lead to acute airway obstruction and asphyxiation in critical situations, such as massive hematemesis, thereby necessitating the implementation of refined and context-specific airway management strategies.

Case description: We present the case of a 66-year-old male with recurrent tongue cancer who experienced a sudden episode of severe hematemesis, leading to acute respiratory distress and loss of consciousness. In this life-threatening situation, with limited resources, percutaneous transtracheal ventilation (PTV) was performed using basic, readily available equipment. The procedure was complemented by an intermittent oral-nasal occlusion technique to simulate breathing and maintain oxygenation. Despite challenges such as anatomical distortion and significant bleeding, these interventions successfully stabilized the patient's condition, raising oxygen saturation to 100%. Following stabilization, the patient underwent a complex tracheostomy.

Conclusions: This case underscores the effectiveness of combining fine-needle cricothyroid puncture with intermittent oral-nasal occlusion as a practical and resource-efficient method to maintain ventilation in emergency airway obstruction scenarios. This approach offers a valuable strategy for managing challenging airways in cancer patients, particularly when resources are scarce or time is critical.

背景:晚期舌癌患者由于先前手术和放疗引起的解剖改变,往往面临气道管理困难的风险增加。这些改变可能导致急性气道阻塞和窒息在危急情况下,如大量呕血,因此需要实施精细和具体的气道管理策略。病例描述:我们报告一位66岁男性复发舌癌患者,他突然出现严重呕血,导致急性呼吸窘迫和意识丧失。在这种危及生命的情况下,由于资源有限,我们使用基本的、现成的设备进行了经皮经气管通气(PTV)。该程序辅以间歇口鼻闭塞技术,以模拟呼吸和维持氧合。尽管存在解剖扭曲和大量出血等挑战,但这些干预措施成功地稳定了患者的病情,将血氧饱和度提高到100%。病情稳定后,患者接受了复杂的气管切开术。结论:本病例强调了细针环甲穿刺联合间歇性口鼻阻塞作为一种实用且资源有效的方法在紧急气道阻塞情况下维持通气的有效性。这种方法为癌症患者管理气道提供了一种有价值的策略,特别是在资源稀缺或时间紧迫的情况下。
{"title":"Improved percutaneous transtracheal ventilation for airway obstruction in tongue cancer: a case report.","authors":"Liangyu Zheng, Youfa Zhou, Dachun Zhou","doi":"10.21037/acr-2025-101","DOIUrl":"10.21037/acr-2025-101","url":null,"abstract":"<p><strong>Background: </strong>Patients with advanced-stage tongue cancer are often confronted with an increased risk of difficult airway management due to anatomical changes caused by prior surgeries and radiation therapy. These alterations may lead to acute airway obstruction and asphyxiation in critical situations, such as massive hematemesis, thereby necessitating the implementation of refined and context-specific airway management strategies.</p><p><strong>Case description: </strong>We present the case of a 66-year-old male with recurrent tongue cancer who experienced a sudden episode of severe hematemesis, leading to acute respiratory distress and loss of consciousness. In this life-threatening situation, with limited resources, percutaneous transtracheal ventilation (PTV) was performed using basic, readily available equipment. The procedure was complemented by an intermittent oral-nasal occlusion technique to simulate breathing and maintain oxygenation. Despite challenges such as anatomical distortion and significant bleeding, these interventions successfully stabilized the patient's condition, raising oxygen saturation to 100%. Following stabilization, the patient underwent a complex tracheostomy.</p><p><strong>Conclusions: </strong>This case underscores the effectiveness of combining fine-needle cricothyroid puncture with intermittent oral-nasal occlusion as a practical and resource-efficient method to maintain ventilation in emergency airway obstruction scenarios. This approach offers a valuable strategy for managing challenging airways in cancer patients, particularly when resources are scarce or time is critical.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"141"},"PeriodicalIF":0.7,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implant-based oral rehabilitation in patients with special needs: a case report. 特殊需要患者基于种植体的口腔康复一例报告。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-11 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-110
Lidan Huang, Jiaxing Gong, Kejie Lu, Xia Zhang, Zhicheng Xu, Mengfei Yu, Misi Si, Huiming Wang

Background: In poliomyelitis survivors, approximately 1% of patients experience long-term motor dysfunction, which includes symptoms such as reduced muscle strength, asymmetric paralysis, muscle atrophy, and joint deformities. These chronic sequelae contribute to the decline in their ability to maintain proper oral hygiene, leading to a significantly higher incidence of oral diseases and, ultimately, tooth loss. Oral implant technology provides a potential therapeutic solution for edentulous and partially edentulous patients. However, in such patients with pre-existing limitations, conventional dental implant surgery under local anesthesia (LA) is often complicated by greater operational constraints, higher technical complexity, and reduced safety. Therefore, general anesthesia (GA) is frequently employed to facilitate oral rehabilitation procedures in uncooperative patients, thus establishing the foundation for comprehensive dental care.

Case description: A 27-year-old woman with a history of poliomyelitis is scheduled to receive multiple dental implants in both her upper and lower jaws, along with a maxillary sinus lift, under GA. This procedure also got a digital restoration six months post-surgery. Postoperative assessments show successful integration of the implants and effective restoration.

Conclusions: Combining GA with implant technology presents a viable and effective treatment option for improving edentulous conditions in patients with physical and cognitive impairments.

背景:在脊髓灰质炎幸存者中,大约1%的患者经历长期运动功能障碍,包括肌肉力量下降、不对称麻痹、肌肉萎缩和关节畸形等症状。这些慢性后遗症导致他们保持适当口腔卫生的能力下降,导致口腔疾病的发生率大大增加,并最终导致牙齿脱落。口腔种植技术为无牙和部分无牙患者提供了一种潜在的治疗方案。然而,对于这些已有局限性的患者,传统的局部麻醉种植牙手术(LA)往往由于更大的操作限制、更高的技术复杂性和降低的安全性而复杂化。因此,全麻(GA)经常被用于促进不合作患者的口腔康复手术,从而为全面的牙科护理奠定基础。病例描述:一名有脊髓灰质炎病史的27岁女性,计划在GA下接受上颌和下颚多处种植牙,同时上颌窦提升。该手术在术后6个月也获得了数字恢复。术后评估显示种植体的成功整合和有效的修复。结论:GA联合种植体技术是改善身体和认知障碍患者无牙状态的一种可行有效的治疗选择。
{"title":"Implant-based oral rehabilitation in patients with special needs: a case report.","authors":"Lidan Huang, Jiaxing Gong, Kejie Lu, Xia Zhang, Zhicheng Xu, Mengfei Yu, Misi Si, Huiming Wang","doi":"10.21037/acr-2025-110","DOIUrl":"10.21037/acr-2025-110","url":null,"abstract":"<p><strong>Background: </strong>In poliomyelitis survivors, approximately 1% of patients experience long-term motor dysfunction, which includes symptoms such as reduced muscle strength, asymmetric paralysis, muscle atrophy, and joint deformities. These chronic sequelae contribute to the decline in their ability to maintain proper oral hygiene, leading to a significantly higher incidence of oral diseases and, ultimately, tooth loss. Oral implant technology provides a potential therapeutic solution for edentulous and partially edentulous patients. However, in such patients with pre-existing limitations, conventional dental implant surgery under local anesthesia (LA) is often complicated by greater operational constraints, higher technical complexity, and reduced safety. Therefore, general anesthesia (GA) is frequently employed to facilitate oral rehabilitation procedures in uncooperative patients, thus establishing the foundation for comprehensive dental care.</p><p><strong>Case description: </strong>A 27-year-old woman with a history of poliomyelitis is scheduled to receive multiple dental implants in both her upper and lower jaws, along with a maxillary sinus lift, under GA. This procedure also got a digital restoration six months post-surgery. Postoperative assessments show successful integration of the implants and effective restoration.</p><p><strong>Conclusions: </strong>Combining GA with implant technology presents a viable and effective treatment option for improving edentulous conditions in patients with physical and cognitive impairments.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"162"},"PeriodicalIF":0.7,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous sternal fracture in multiparous woman during labor: a case report. 产多胎妇女分娩时自发性胸骨骨折1例报告。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-11 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-106
Tade Popović, Vajdana Tomić, Nikolina Penava, Milena Brkić, Andrej Galić

Background: Spontaneous sternal fracture is an extremely rare cause of chest pain during or after childbirth. To date, only three cases of sternal fracture during childbirth have been reported. This case report represents the first documented case of spontaneous sternal fracture among multiparous women.

Case description: A 33-year-old multiparous woman with an uncomplicated medical history is described, who delivered a healthy fourth infant vaginally at 41 weeks of pregnancy. After the previous three deliveries, each child had been breastfed for more than a year, and the third delivery was eight months before conception, and she breastfed until 3 months of pregnancy. During the final stage of labor, while performing the Valsalva maneuver in the lithotomy position, she felt a sharp, severe chest pain. Postpartum work-up included cardioselective enzymes that were within reference values, and radiological work-up confirmed a non-displaced sternal fracture, which was treated conservatively with symptomatic therapy, with complete recovery after 6 weeks.

Conclusions: This case report suggests the need to consider sternal fracture as a differential diagnostic consideration in women who experience chest pain during or immediately after delivery. Changes in metabolism, especially calcium metabolism during pregnancy and lactation, can result in transient osteopenia and, with increased mechanical stress, cause bone fracture. Special attention should be paid to patients who breastfed immediately before conception or who breastfeed during pregnancy, to vitamin and mineral replacement therapy, adequate nutrition, and physical activity. Timely diagnosis of sternal fracture can significantly reduce the need for expensive and invasive diagnostic tests. Further research is needed on osteopenia in pregnant women, especially multiparous women who are breastfeeding immediately before conception or during pregnancy.

背景:自发性胸骨骨折是一种极为罕见的原因胸痛期间或分娩后。迄今为止,仅报道了3例分娩时胸骨骨折的病例。本病例报告是第一例记录在案的自发性胸骨骨折在多胎妇女。病例描述:一位33岁的多胎妇女,病史简单,在怀孕41周时顺产了健康的第四个婴儿。前三次分娩后,每个孩子都母乳喂养了一年多,第三次分娩是在受孕前8个月,她母乳喂养到怀孕3个月。在分娩的最后阶段,当她在取石位进行Valsalva操作时,她感到一阵剧烈的胸痛。产后检查包括心脏选择酶在参考值范围内,影像学检查证实为非移位性胸骨骨折,经对症治疗保守治疗,6周后完全恢复。结论:本病例报告提示,在分娩时或分娩后出现胸痛的妇女,需要将胸骨骨折作为鉴别诊断的考虑因素。妊娠和哺乳期代谢的变化,尤其是钙代谢的变化,可导致短暂性骨质减少,并随着机械应力的增加,导致骨折。应特别注意孕前立即母乳喂养或怀孕期间母乳喂养的患者,维生素和矿物质替代疗法,充足的营养和身体活动。及时诊断胸骨骨折可以大大减少昂贵的侵入性诊断检查的需要。需要进一步研究孕妇骨质减少,特别是在怀孕前或怀孕期间进行母乳喂养的多胎妇女。
{"title":"Spontaneous sternal fracture in multiparous woman during labor: a case report.","authors":"Tade Popović, Vajdana Tomić, Nikolina Penava, Milena Brkić, Andrej Galić","doi":"10.21037/acr-2025-106","DOIUrl":"10.21037/acr-2025-106","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous sternal fracture is an extremely rare cause of chest pain during or after childbirth. To date, only three cases of sternal fracture during childbirth have been reported. This case report represents the first documented case of spontaneous sternal fracture among multiparous women.</p><p><strong>Case description: </strong>A 33-year-old multiparous woman with an uncomplicated medical history is described, who delivered a healthy fourth infant vaginally at 41 weeks of pregnancy. After the previous three deliveries, each child had been breastfed for more than a year, and the third delivery was eight months before conception, and she breastfed until 3 months of pregnancy. During the final stage of labor, while performing the Valsalva maneuver in the lithotomy position, she felt a sharp, severe chest pain. Postpartum work-up included cardioselective enzymes that were within reference values, and radiological work-up confirmed a non-displaced sternal fracture, which was treated conservatively with symptomatic therapy, with complete recovery after 6 weeks.</p><p><strong>Conclusions: </strong>This case report suggests the need to consider sternal fracture as a differential diagnostic consideration in women who experience chest pain during or immediately after delivery. Changes in metabolism, especially calcium metabolism during pregnancy and lactation, can result in transient osteopenia and, with increased mechanical stress, cause bone fracture. Special attention should be paid to patients who breastfed immediately before conception or who breastfeed during pregnancy, to vitamin and mineral replacement therapy, adequate nutrition, and physical activity. Timely diagnosis of sternal fracture can significantly reduce the need for expensive and invasive diagnostic tests. Further research is needed on osteopenia in pregnant women, especially multiparous women who are breastfeeding immediately before conception or during pregnancy.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"109"},"PeriodicalIF":0.7,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report. her2阳性转移性乳腺癌中与曲妥珠单抗德鲁西替康耐药相关的ErbB信号传导和细胞周期途径:1例报告
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-29 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-118
Hong-Fei Gao, Ying-Yi Lin, Xin-Ze Lv, Hong Li, Fang-Ping Xu, Kun Wang

Background: Trastuzumab deruxtecan (T-DXd) significantly improves human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) outcomes. However, understanding of resistance mechanisms to T-DXd remains limited. Here, we present a case of a luminal B, HER2-positive MBC who displayed a partial response to T-DXd following five lines of prior HER2-targeted therapy but developed acquired resistance after 14 months of treatment. Organoid drug screening identified the potential strategy to overcome T-DXd resistance. Next-generation sequencing (NGS) of 550 cancer-associated genes was performed prior to T-DXd administration, and repeated after the emergence of T-DXd resistance.

Case description: We present a case of a luminal B, HER2-positive MBC. T-DXd was administered as the sixth-line regimen, resulting in a dramatic clinical response with near-complete resolution of the gluteal mass. After 14 months of therapy, the patient developed progressive cervical lymphadenopathy. Patient-derived organoids were generated, and subsequent drug screening was performed, which identified anlotinib plus T-DXd as a potential candidate regimen. She was then treated with anlotinib and T-DXd and had disease control for 6 months before progressive liver metastases were observed. Genomic analysis further revealed aberrations in the ErbB signaling and cell cycle pathways that might be implicated in the emergence of T-DXd resistance.

Conclusions: This case suggests that T-DXd resistance may be attributed to dysregulation in the ErbB signaling and cell cycle pathways. In vitro experiments are being conducted to ascertain the potential benefits of targeted inhibition of angiogenesis or cell cycle proteins in overcoming T-DXd resistance. Nevertheless, more cases and follow-up information are needed to support these views.

背景:曲妥珠单抗德鲁西替康(T-DXd)可显著改善人表皮生长因子受体2 (HER2)阳性转移性乳腺癌(MBC)的预后。然而,对T-DXd耐药机制的了解仍然有限。在这里,我们报告了一例luminal B, her2阳性MBC患者,他在先前的5个her2靶向治疗后对T-DXd表现出部分反应,但在治疗14个月后出现了获得性耐药。类器官药物筛选确定了克服T-DXd耐药的潜在策略。在给药前对550个癌症相关基因进行下一代测序(NGS),并在出现T-DXd耐药后重复。病例描述:我们报告一例管腔B, her2阳性MBC。T-DXd作为第六线治疗方案,导致显著的临床反应,臀肿块几乎完全消退。治疗14个月后,患者出现进行性颈淋巴肿大。生成了患者来源的类器官,随后进行了药物筛选,确定了anlotinib + T-DXd作为潜在的候选方案。随后给予安洛替尼和T-DXd治疗,病情控制6个月后观察到进展性肝转移。基因组分析进一步揭示了ErbB信号通路和细胞周期通路的畸变可能与T-DXd耐药性的出现有关。结论:该病例提示T-DXd耐药可能归因于ErbB信号通路和细胞周期通路的失调。目前正在进行体外实验,以确定靶向抑制血管生成或细胞周期蛋白在克服T-DXd耐药性方面的潜在益处。然而,需要更多的案例和后续信息来支持这些观点。
{"title":"ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.","authors":"Hong-Fei Gao, Ying-Yi Lin, Xin-Ze Lv, Hong Li, Fang-Ping Xu, Kun Wang","doi":"10.21037/acr-2025-118","DOIUrl":"10.21037/acr-2025-118","url":null,"abstract":"<p><strong>Background: </strong>Trastuzumab deruxtecan (T-DXd) significantly improves human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) outcomes. However, understanding of resistance mechanisms to T-DXd remains limited. Here, we present a case of a luminal B, HER2-positive MBC who displayed a partial response to T-DXd following five lines of prior HER2-targeted therapy but developed acquired resistance after 14 months of treatment. Organoid drug screening identified the potential strategy to overcome T-DXd resistance. Next-generation sequencing (NGS) of 550 cancer-associated genes was performed prior to T-DXd administration, and repeated after the emergence of T-DXd resistance.</p><p><strong>Case description: </strong>We present a case of a luminal B, HER2-positive MBC. T-DXd was administered as the sixth-line regimen, resulting in a dramatic clinical response with near-complete resolution of the gluteal mass. After 14 months of therapy, the patient developed progressive cervical lymphadenopathy. Patient-derived organoids were generated, and subsequent drug screening was performed, which identified anlotinib plus T-DXd as a potential candidate regimen. She was then treated with anlotinib and T-DXd and had disease control for 6 months before progressive liver metastases were observed. Genomic analysis further revealed aberrations in the ErbB signaling and cell cycle pathways that might be implicated in the emergence of T-DXd resistance.</p><p><strong>Conclusions: </strong>This case suggests that T-DXd resistance may be attributed to dysregulation in the ErbB signaling and cell cycle pathways. <i>In vitro</i> experiments are being conducted to ascertain the potential benefits of targeted inhibition of angiogenesis or cell cycle proteins in overcoming T-DXd resistance. Nevertheless, more cases and follow-up information are needed to support these views.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"118"},"PeriodicalIF":0.7,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful extracorporeal membrane oxygenation for cardiac arrest and cardiogenic shock due to lupus myocarditis: a case report. 成功体外膜氧合治疗狼疮性心肌炎引起的心脏骤停和心源性休克1例。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-26 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-83
Ryosuke Omoto, Yumika Yonao, Takaya Nishiura, Sung Ho Kim, Tomoki Yamada, Yoshihiko Ikeda, Yasuaki Mizushima

Background: Myocarditis due to systemic lupus erythematosus (SLE), also known as lupus myocarditis, is a rare but potentially life-threatening manifestation of this autoimmune disease. Although pericardial involvement is more commonly observed in SLE, myocarditis can occasionally lead to severe cardiac dysfunction and cardiogenic shock. Diagnosis can be challenging due to non-specific symptoms, and early recognition is crucial. Reports of cases requiring advanced circulatory support, such as venous-arterial extracorporeal membrane oxygenation (VA-ECMO), remain extremely limited in the literature.

Case description: We report the case of a 47-year-old woman with a known history of SLE who experienced sudden cardiac arrest at Osaka Keisatsu Hospital. Cardiopulmonary resuscitation was immediately initiated, and return of spontaneous circulation was achieved. Despite this, she remained in prolonged cardiogenic shock unresponsive to conventional therapy, prompting the initiation of VA-ECMO on the day of admission. Laboratory and imaging findings supported the diagnosis of lupus myocarditis and high-dose corticosteroid therapy was commenced promptly. Over the following days, her cardiac function gradually improved, and she was weaned off VA-ECMO on day 6. Remarkably, she demonstrated a full neurological recovery and was eventually discharged without significant sequelae.

Conclusions: This case highlights the severe cardiac complications that can arise in patients with SLE, particularly the rare occurrence of myocarditis leading to cardiogenic shock. The timely use of VA-ECMO provided essential hemodynamic support, allowing for patient stabilization and further management. Early diagnosis, aggressive management, and multidisciplinary care are critical to achieving favorable outcomes in such complex cases.

背景:系统性红斑狼疮(SLE)引起的心肌炎,也称为狼疮性心肌炎,是一种罕见但可能危及生命的自身免疫性疾病。虽然累及心包在SLE中更为常见,但心肌炎偶尔也会导致严重的心功能障碍和心源性休克。由于非特异性症状,诊断可能具有挑战性,早期识别至关重要。需要高级循环支持的病例报告,如静脉-动脉体外膜氧合(VA-ECMO),在文献中仍然非常有限。病例描述:我们报告一位有SLE病史的47岁女性,在大阪Keisatsu医院经历了心脏骤停。立即进行心肺复苏,恢复了自然循环。尽管如此,她仍然处于长时间的心源性休克,对常规治疗无反应,促使在入院当天开始VA-ECMO。实验室和影像学检查结果支持狼疮性心肌炎的诊断,并立即开始大剂量皮质类固醇治疗。随后数日,患者心功能逐渐改善,于第6天停用VA-ECMO。值得注意的是,她表现出完全的神经恢复,并最终出院,没有明显的后遗症。结论:本病例突出了SLE患者可能出现的严重心脏并发症,特别是罕见的心肌炎导致心源性休克。及时使用VA-ECMO提供了必要的血流动力学支持,允许患者稳定和进一步的管理。早期诊断,积极的管理和多学科的护理是在这种复杂的情况下取得良好结果的关键。
{"title":"Successful extracorporeal membrane oxygenation for cardiac arrest and cardiogenic shock due to lupus myocarditis: a case report.","authors":"Ryosuke Omoto, Yumika Yonao, Takaya Nishiura, Sung Ho Kim, Tomoki Yamada, Yoshihiko Ikeda, Yasuaki Mizushima","doi":"10.21037/acr-2025-83","DOIUrl":"10.21037/acr-2025-83","url":null,"abstract":"<p><strong>Background: </strong>Myocarditis due to systemic lupus erythematosus (SLE), also known as lupus myocarditis, is a rare but potentially life-threatening manifestation of this autoimmune disease. Although pericardial involvement is more commonly observed in SLE, myocarditis can occasionally lead to severe cardiac dysfunction and cardiogenic shock. Diagnosis can be challenging due to non-specific symptoms, and early recognition is crucial. Reports of cases requiring advanced circulatory support, such as venous-arterial extracorporeal membrane oxygenation (VA-ECMO), remain extremely limited in the literature.</p><p><strong>Case description: </strong>We report the case of a 47-year-old woman with a known history of SLE who experienced sudden cardiac arrest at Osaka Keisatsu Hospital. Cardiopulmonary resuscitation was immediately initiated, and return of spontaneous circulation was achieved. Despite this, she remained in prolonged cardiogenic shock unresponsive to conventional therapy, prompting the initiation of VA-ECMO on the day of admission. Laboratory and imaging findings supported the diagnosis of lupus myocarditis and high-dose corticosteroid therapy was commenced promptly. Over the following days, her cardiac function gradually improved, and she was weaned off VA-ECMO on day 6. Remarkably, she demonstrated a full neurological recovery and was eventually discharged without significant sequelae.</p><p><strong>Conclusions: </strong>This case highlights the severe cardiac complications that can arise in patients with SLE, particularly the rare occurrence of myocarditis leading to cardiogenic shock. The timely use of VA-ECMO provided essential hemodynamic support, allowing for patient stabilization and further management. Early diagnosis, aggressive management, and multidisciplinary care are critical to achieving favorable outcomes in such complex cases.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"134"},"PeriodicalIF":0.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual case of topiramate-induced auditory-visual synaesthesia in a non-synaesthete young adult: a case report. 不寻常的情况下,托吡酯诱导的听觉-视觉联觉在一个非联觉的年轻人:一个病例报告。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-26 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-103
Yousuf Yaqub, Pratik Ramkumar, Waseem Jerjes

Background: Synaesthesia is a perceptual phenomenon where stimulation of one sensory modality leads to automatic experiences in another. While often congenital, acquired forms-particularly pharmacologically induced synaesthesia-are rare and poorly understood. Topiramate, an antiepileptic and migraine prophylactic agent, affects neuronal excitability and sensory integration, but its association with synaesthesia has rarely been documented.

Case description: We report the case of a 28-year-old male software engineer with no prior neurological or psychiatric history who developed auditory-visual synaesthesia two weeks after initiating topiramate for migraine prophylaxis. The patient consistently visualised specific colours in response to particular environmental sounds such as phone rings and rainfall. Clinical examination, neurological evaluation, and comprehensive diagnostic workup-including brain magnetic resonance imaging (MRI), audiological, and ophthalmological assessments-were normal, excluding structural lesions and primary sensory abnormalities. The symptoms, although non-distressing, significantly intrigued the patient, prompting medical consultation. Symptoms resolved gradually over eight weeks following discontinuation of topiramate, supporting a diagnosis of drug-induced synaesthesia. The patient was subsequently started on propranolol for migraine management, which was well-tolerated, effectively controlled migraines, and did not trigger any recurrence of synaesthetic experiences.

Conclusions: This case highlights a rare but clinically relevant side effect of topiramate and underscores the importance of thorough medication history in evaluating atypical sensory experiences. Primary care clinicians should consider pharmacological causes in sudden-onset synaesthesia, ensuring prompt identification, appropriate referral, and alternative treatment planning.

背景:联觉是一种知觉现象,其中一种感觉模态的刺激导致另一种感觉模态的自动体验。虽然通常是先天性的,但获得性的形式-特别是药物诱导的联觉-是罕见的,而且知之甚少。托吡酯是一种抗癫痫和预防偏头痛的药物,影响神经元兴奋性和感觉统合,但其与联觉的关系很少有文献记载。病例描述:我们报告了一个28岁的男性软件工程师,没有先前的神经或精神病史,在开始服用托吡酯预防偏头痛两周后出现了听觉-视觉联觉。病人总是对特定的环境声音(如电话铃声和降雨)做出反应,想象出特定的颜色。临床检查、神经学评估和综合诊断检查(包括脑磁共振成像(MRI)、听力学和眼科评估)均正常,排除结构性病变和原发性感觉异常。这些症状虽然不令人痛苦,但却引起了病人的极大兴趣,促使他们去看医生。停用托吡酯后8周症状逐渐缓解,支持药物性联觉的诊断。随后,患者开始服用心得安治疗偏头痛。心得安耐受性良好,有效地控制了偏头痛,并且没有引发任何联觉体验的复发。结论:本病例突出了托吡酯罕见但临床相关的副作用,并强调了在评估非典型感觉体验时全面用药史的重要性。初级保健临床医生应考虑突发性联觉的药理学原因,确保及时识别,适当转诊和替代治疗计划。
{"title":"Unusual case of topiramate-induced auditory-visual synaesthesia in a non-synaesthete young adult: a case report.","authors":"Yousuf Yaqub, Pratik Ramkumar, Waseem Jerjes","doi":"10.21037/acr-2025-103","DOIUrl":"10.21037/acr-2025-103","url":null,"abstract":"<p><strong>Background: </strong>Synaesthesia is a perceptual phenomenon where stimulation of one sensory modality leads to automatic experiences in another. While often congenital, acquired forms-particularly pharmacologically induced synaesthesia-are rare and poorly understood. Topiramate, an antiepileptic and migraine prophylactic agent, affects neuronal excitability and sensory integration, but its association with synaesthesia has rarely been documented.</p><p><strong>Case description: </strong>We report the case of a 28-year-old male software engineer with no prior neurological or psychiatric history who developed auditory-visual synaesthesia two weeks after initiating topiramate for migraine prophylaxis. The patient consistently visualised specific colours in response to particular environmental sounds such as phone rings and rainfall. Clinical examination, neurological evaluation, and comprehensive diagnostic workup-including brain magnetic resonance imaging (MRI), audiological, and ophthalmological assessments-were normal, excluding structural lesions and primary sensory abnormalities. The symptoms, although non-distressing, significantly intrigued the patient, prompting medical consultation. Symptoms resolved gradually over eight weeks following discontinuation of topiramate, supporting a diagnosis of drug-induced synaesthesia. The patient was subsequently started on propranolol for migraine management, which was well-tolerated, effectively controlled migraines, and did not trigger any recurrence of synaesthetic experiences.</p><p><strong>Conclusions: </strong>This case highlights a rare but clinically relevant side effect of topiramate and underscores the importance of thorough medication history in evaluating atypical sensory experiences. Primary care clinicians should consider pharmacological causes in sudden-onset synaesthesia, ensuring prompt identification, appropriate referral, and alternative treatment planning.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"133"},"PeriodicalIF":0.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic disseminated mycobacterium infection: a case report and a literature review. 肝播散性分枝杆菌感染1例并文献复习。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-26 eCollection Date: 2025-01-01 DOI: 10.21037/acr-25-48
Dongliang Li, Yanmei Zheng, Xiulan Ao, Qinghong Liu, Zhiyong Zheng, Shaohua Chen

Background: Non-tuberculous mycobacteria (NTM), considered to be less virulent and being pathogenic. People with normal immune function are less likely to be infected. Systemic disseminated infections that spread to the abdominal tissues and organs such as the liver rarely occur with NTM.

Case description: Here, we perform a literature review and report a rare case of disseminated Mycobacterium fortuitum infection with involvement of the liver and hilar lymph node from a 44-year-old immunocompetent woman. The patient experienced prolonged fever and cholecystolithiasis with cholecystitis. Exploratory laparotomy revealed numerous white nodules covering the liver surface and enlarged lymph nodes in the hepatic hilum. Histopathological analysis showed inflammatory granulomas. Auramine O fluorescence staining and acid-fast staining revealed morphological features consistent with NTM. Fluorescence polymerase chain reaction (PCR) melting curve analysis confirmed the presence of Mycobacterium fortuitum. Following diagnosis, the patient was treated with rifampin, isoniazid, pyrazinamide, ethambutol, and clarithromycin. The fever subsided, abdominal pain resolved, and liver function improved, enabling the patient to be discharged. However, 3 months into continued oral administration of these medications, the symptoms recurred. Suspected drug resistance to Mycobacterium fortuitum prompted adjustment of the treatment regimen to alternative antimycobacterial agents. Despite these efforts, due to the unique characteristics of the infection site, repeated sampling for NTM culture and drug susceptibility testing was not feasible, making it impossible to select anti-NTM agents based on susceptibility results. Consequently, the therapeutic response was suboptimal, and the patient ultimately succumbed to multi-organ failure.

Conclusions: For patients with multi-organ disseminated infection involving the liver, conventional anti-tuberculosis drugs are less effective, and the infection continues to pose a serious threat that should be considered a high priority. When formulating NTM chemotherapy regimens, combination therapy should be selected based on drug susceptibility testing results, and ongoing monitoring of both drug sensitivity and safety should be ensured throughout the treatment process.

背景:非结核分枝杆菌(NTM),被认为毒性较小,具有致病性。免疫功能正常的人不太可能被感染。扩散到腹部组织和器官(如肝脏)的系统性播散性感染很少发生在NTM中。病例描述:在此,我们进行文献回顾并报告一例罕见的弥散性偶发分枝杆菌感染,累及肝脏和肝门淋巴结,患者为44岁免疫功能正常的女性。患者出现长期发热和胆囊结石合并胆囊炎。剖腹探查发现肝表面可见大量白色结节,肝门淋巴结肿大。组织病理学分析为炎性肉芽肿。Auramine O荧光染色和抗酸染色显示与NTM一致的形态学特征。荧光聚合酶链反应(PCR)熔融曲线分析证实了福氏分枝杆菌的存在。确诊后,患者给予利福平、异烟肼、吡嗪酰胺、乙胺丁醇和克拉霉素治疗。发热消退,腹痛缓解,肝功能改善,出院。然而,持续口服这些药物3个月后,症状复发。对偶然性分枝杆菌的疑似耐药性促使患者调整治疗方案,改用其他抗真菌药物。尽管如此,由于感染部位的独特性,NTM培养和药敏试验的重复采样是不可实现的,因此无法根据药敏结果选择抗NTM药物。因此,治疗效果不理想,患者最终死于多器官衰竭。结论:对于累及肝脏的多器官播散性感染患者,常规抗结核药物效果较差,感染持续构成严重威胁,应予以高度重视。在制定NTM化疗方案时,应根据药敏试验结果选择联合治疗方案,并在整个治疗过程中持续监测药物敏感性和安全性。
{"title":"Hepatic disseminated mycobacterium infection: a case report and a literature review.","authors":"Dongliang Li, Yanmei Zheng, Xiulan Ao, Qinghong Liu, Zhiyong Zheng, Shaohua Chen","doi":"10.21037/acr-25-48","DOIUrl":"10.21037/acr-25-48","url":null,"abstract":"<p><strong>Background: </strong><i>Non-tuberculous mycobacteria</i> (NTM), considered to be less virulent and being pathogenic. People with normal immune function are less likely to be infected. Systemic disseminated infections that spread to the abdominal tissues and organs such as the liver rarely occur with NTM.</p><p><strong>Case description: </strong>Here, we perform a literature review and report a rare case of disseminated <i>Mycobacterium fortuitum</i> infection with involvement of the liver and hilar lymph node from a 44-year-old immunocompetent woman. The patient experienced prolonged fever and cholecystolithiasis with cholecystitis. Exploratory laparotomy revealed numerous white nodules covering the liver surface and enlarged lymph nodes in the hepatic hilum. Histopathological analysis showed inflammatory granulomas. Auramine O fluorescence staining and acid-fast staining revealed morphological features consistent with NTM. Fluorescence polymerase chain reaction (PCR) melting curve analysis confirmed the presence of <i>Mycobacterium fortuitum</i>. Following diagnosis, the patient was treated with rifampin, isoniazid, pyrazinamide, ethambutol, and clarithromycin. The fever subsided, abdominal pain resolved, and liver function improved, enabling the patient to be discharged. However, 3 months into continued oral administration of these medications, the symptoms recurred. Suspected drug resistance to <i>Mycobacterium fortuitum</i> prompted adjustment of the treatment regimen to alternative antimycobacterial agents. Despite these efforts, due to the unique characteristics of the infection site, repeated sampling for NTM culture and drug susceptibility testing was not feasible, making it impossible to select anti-NTM agents based on susceptibility results. Consequently, the therapeutic response was suboptimal, and the patient ultimately succumbed to multi-organ failure.</p><p><strong>Conclusions: </strong>For patients with multi-organ disseminated infection involving the liver, conventional anti-tuberculosis drugs are less effective, and the infection continues to pose a serious threat that should be considered a high priority. When formulating NTM chemotherapy regimens, combination therapy should be selected based on drug susceptibility testing results, and ongoing monitoring of both drug sensitivity and safety should be ensured throughout the treatment process.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"119"},"PeriodicalIF":0.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overlooked parahiatal hernia: diagnostic challenges and implications of a case report. 被忽视的腹旁疝:一个病例报告的诊断挑战和意义。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-26 eCollection Date: 2025-01-01 DOI: 10.21037/acr-25-26
Aarohi Parikh, Trishna Parikh, Ismail Hader

Background: Parahiatal hernias (PHHs) comprise of less than 1% of all diaphragmatic hernias and are frequently mistaken for paraesophageal hernias due to their close anatomical proximity to the esophageal hiatus. Unlike classic hiatal hernias PHH herniate laterally through a defect in the left crus separated from the esophageal hiatus. Because of their rarity and diagnostic ambiguity, PHHs are underrecognized and often incidentally found during imaging or endoscopy. The etiology can be congenital or acquired with known risk factors including trauma, prior esophageal and abdominal surgeries, or diaphragmatic weakness.

Case description: We present a case of a 73-year-old female with a history of small cell lung malignancy treated with thoracic radiation who was admitted for symptomatic anemia. While being evaluated for odynophagia and suspected esophagitis an esophagogastroduodenoscopy (EGD) initially revealed a paraesophageal hernia. However, upon further review of the EGD images it was diagnosed as a PHH. Notably, a previous EGD two years prior had shown no such hernia suggesting an acquired defect possibly radiation induced. The patient's symptoms improved with medical management for esophagitis and no surgical intervention was required due to the hernia's small size and absence of complications.

Conclusions: This case emphasizes the importance of distinguishing PHH from other hiatal hernias, particularly in elderly patients with complex medical histories. Misclassification may lead to inappropriate management especially if surgical repair is needed. While congenital and traumatic causes are well established this case introduces radiation therapy as a potential contributing factor to acquired PHH, a connection not previously documented in literature. Clinicians should maintain a high index of suspicion for PHHs during endoscopic or radiologic evaluation, especially when the hernia anatomy appears atypical. Early and accurate diagnosis is essential to guide appropriate treatment and prevent unnecessary surgical intervention if not indicated.

背景:食管旁疝(PHHs)占所有膈疝的不到1%,由于其解剖学上接近食管裂孔,经常被误认为是食管旁疝。与典型的食管裂孔疝不同,PHH通过与食管裂孔分离的左小腿缺损向外侧疝出。由于其罕见性和诊断模糊性,phh未被充分认识,通常在成像或内窥镜检查中偶然发现。病因可以是先天性的,也可以是后天的,并伴有已知的危险因素,包括创伤、既往食管和腹部手术或膈肌无力。病例描述:我们报告一例73岁女性,有小细胞肺恶性肿瘤病史,接受胸部放射治疗,因症状性贫血入院。在评估食管吞咽和疑似食管炎时,食管胃十二指肠镜(EGD)最初显示为食管旁疝。然而,在进一步检查EGD图像后,诊断为PHH。值得注意的是,两年前的EGD没有显示出这种疝气,这表明可能是辐射引起的获得性缺陷。患者的食管炎经药物治疗后症状得到改善,由于疝体积小且无并发症,无需手术干预。结论:本病例强调了区分PHH与其他裂孔疝的重要性,特别是在有复杂病史的老年患者中。分类错误可能导致处理不当,特别是如果需要手术修复。虽然先天性和创伤性原因已经确定,但本病例介绍了放射治疗作为获得性PHH的潜在促成因素,这一联系在以前的文献中没有记载。临床医生在内镜或放射学评估时应保持对phh的高度怀疑,特别是当疝解剖表现不典型时。早期和准确的诊断对于指导适当的治疗和防止不必要的手术干预至关重要。
{"title":"Overlooked parahiatal hernia: diagnostic challenges and implications of a case report.","authors":"Aarohi Parikh, Trishna Parikh, Ismail Hader","doi":"10.21037/acr-25-26","DOIUrl":"10.21037/acr-25-26","url":null,"abstract":"<p><strong>Background: </strong>Parahiatal hernias (PHHs) comprise of less than 1% of all diaphragmatic hernias and are frequently mistaken for paraesophageal hernias due to their close anatomical proximity to the esophageal hiatus. Unlike classic hiatal hernias PHH herniate laterally through a defect in the left crus separated from the esophageal hiatus. Because of their rarity and diagnostic ambiguity, PHHs are underrecognized and often incidentally found during imaging or endoscopy. The etiology can be congenital or acquired with known risk factors including trauma, prior esophageal and abdominal surgeries, or diaphragmatic weakness.</p><p><strong>Case description: </strong>We present a case of a 73-year-old female with a history of small cell lung malignancy treated with thoracic radiation who was admitted for symptomatic anemia. While being evaluated for odynophagia and suspected esophagitis an esophagogastroduodenoscopy (EGD) initially revealed a paraesophageal hernia. However, upon further review of the EGD images it was diagnosed as a PHH. Notably, a previous EGD two years prior had shown no such hernia suggesting an acquired defect possibly radiation induced. The patient's symptoms improved with medical management for esophagitis and no surgical intervention was required due to the hernia's small size and absence of complications.</p><p><strong>Conclusions: </strong>This case emphasizes the importance of distinguishing PHH from other hiatal hernias, particularly in elderly patients with complex medical histories. Misclassification may lead to inappropriate management especially if surgical repair is needed. While congenital and traumatic causes are well established this case introduces radiation therapy as a potential contributing factor to acquired PHH, a connection not previously documented in literature. Clinicians should maintain a high index of suspicion for PHHs during endoscopic or radiologic evaluation, especially when the hernia anatomy appears atypical. Early and accurate diagnosis is essential to guide appropriate treatment and prevent unnecessary surgical intervention if not indicated.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"136"},"PeriodicalIF":0.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment process of ALK and ROS1 double-rearranged lung adenocarcinoma cell carcinoma: a case report. ALK、ROS1双重排肺腺癌细胞癌1例治疗过程
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-26 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-92
Jianjun Zou, Hao Wu, Dongming Xie, Jiawei Liu, Chenhua Weng, Jiachun Lu

Background: Anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1 (ROS1) rearrangements are vital oncogenic drivers in non-small cell lung cancer (NSCLC), particularly in lung adenocarcinoma (LUAD), with positivity rates of 2.6% and 1.4% respectively, and are critical prognostic and predictive markers. These two rearrangements are mutually exclusive in most cases, and their co-occurrence is exceptionally rare in existing literature. Therefore, the clinical behavior, therapeutic responses, and optimal treatment strategies for this dual-rearranged subtype are poorly characterized. This case report aims to explore the efficacy of chemotherapy in this rare subtype.

Case description: A 47-year-old never-smoker woman presented with a persistent dry cough and dyspnea. Imaging and biopsy confirmed stage IV (cT2N2M1b) poorly differentiated LUAD with metastases to the mediastinal lymph nodes, pleura, and orbit. Comprehensive molecular profiling identified concurrent ALK and ROS1 rearrangements. The patient received first-line chemotherapy with pemetrexed (820 mg on day 1) plus cisplatin (40 mg on days 1-3) every 21 days and achieved a remarkable progression-free survival (PFS) of 48 months. Upon disease progression at four years, with new pulmonary and cerebral lesions, DNA-based next-generation sequencing (NGS) revealed an echinoderm microtubule-associated protein-like 4 (EML4) exon 13-ALK exon 20 fusion with a variant frequency of 10.33%. She was subsequently treated with ensartinib (225 mg once daily), yielding a favorable response. Treatment remains ongoing.

Conclusions: This case highlights that first-line pemetrexed-cisplatin chemotherapy can yield prolonged disease control in NSCLC harboring dual ALK/ROS1 rearrangements, followed effectively by targeted therapy. It underscores the importance of high-precision molecular profiling to guide sequential treatment strategies. Although tyrosine kinase inhibitors remain the cornerstone for ALK- or ROS1-positive NSCLC, the ideal initial approach for concurrent ALK/ROS1 fusions is yet to be established. Unless there are studies with large cohorts clarifying the case, an individualized regimen-potentially starting with chemotherapy and transitioning to targeted agents-may be justified. Further clinical experience and collaborative research are essential to develop evidence-based guidelines for this exceptionally rare subset.

背景:间变性淋巴瘤激酶(ALK)和ROS原癌基因1 (ROS1)重排是非小细胞肺癌(NSCLC),特别是肺腺癌(LUAD)中重要的致癌驱动因素,阳性率分别为2.6%和1.4%,是关键的预后和预测指标。这两种重排在大多数情况下是相互排斥的,它们的共存在现有文献中是极其罕见的。因此,这种双重重排亚型的临床行为、治疗反应和最佳治疗策略尚不清楚。本病例报告旨在探讨化疗对这种罕见亚型的疗效。病例描述:一名47岁从不吸烟的女性,表现为持续干咳和呼吸困难。影像学和活检证实为IV期(cT2N2M1b)低分化LUAD,并转移到纵隔淋巴结、胸膜和眼眶。综合分子分析发现ALK和ROS1同时重排。患者每21天接受一线化疗,培美曲塞(第1天820 mg)加顺铂(第1-3天40 mg),取得了48个月的显著无进展生存期(PFS)。在疾病进展四年后,出现新的肺部和脑部病变,基于dna的下一代测序(NGS)显示棘皮微管相关蛋白样4 (EML4)外显子13-ALK外显子20融合,变异频率为10.33%。随后,她接受恩沙替尼治疗(225mg,每日一次),产生良好的反应。治疗仍在进行中。结论:该病例表明,在ALK/ROS1双重排的NSCLC患者中,一线培美曲塞-顺铂化疗可以延长疾病控制时间,随后进行有效的靶向治疗。它强调了高精度分子谱对指导序贯治疗策略的重要性。尽管酪氨酸激酶抑制剂仍然是ALK-或ROS1阳性NSCLC的基础,但ALK/ROS1同时融合的理想初始方法尚未建立。除非有大规模的研究来澄清这个问题,否则个体化治疗方案——可能从化疗开始,然后过渡到靶向药物——可能是合理的。进一步的临床经验和合作研究对于为这一极为罕见的人群制定循证指南至关重要。
{"title":"Treatment process of ALK and ROS1 double-rearranged lung adenocarcinoma cell carcinoma: a case report.","authors":"Jianjun Zou, Hao Wu, Dongming Xie, Jiawei Liu, Chenhua Weng, Jiachun Lu","doi":"10.21037/acr-2025-92","DOIUrl":"10.21037/acr-2025-92","url":null,"abstract":"<p><strong>Background: </strong>Anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1 (ROS1) rearrangements are vital oncogenic drivers in non-small cell lung cancer (NSCLC), particularly in lung adenocarcinoma (LUAD), with positivity rates of 2.6% and 1.4% respectively, and are critical prognostic and predictive markers. These two rearrangements are mutually exclusive in most cases, and their co-occurrence is exceptionally rare in existing literature. Therefore, the clinical behavior, therapeutic responses, and optimal treatment strategies for this dual-rearranged subtype are poorly characterized. This case report aims to explore the efficacy of chemotherapy in this rare subtype.</p><p><strong>Case description: </strong>A 47-year-old never-smoker woman presented with a persistent dry cough and dyspnea. Imaging and biopsy confirmed stage IV (cT2N2M1b) poorly differentiated LUAD with metastases to the mediastinal lymph nodes, pleura, and orbit. Comprehensive molecular profiling identified concurrent ALK and ROS1 rearrangements. The patient received first-line chemotherapy with pemetrexed (820 mg on day 1) plus cisplatin (40 mg on days 1-3) every 21 days and achieved a remarkable progression-free survival (PFS) of 48 months. Upon disease progression at four years, with new pulmonary and cerebral lesions, DNA-based next-generation sequencing (NGS) revealed an echinoderm microtubule-associated protein-like 4 (EML4) exon 13-ALK exon 20 fusion with a variant frequency of 10.33%. She was subsequently treated with ensartinib (225 mg once daily), yielding a favorable response. Treatment remains ongoing.</p><p><strong>Conclusions: </strong>This case highlights that first-line pemetrexed-cisplatin chemotherapy can yield prolonged disease control in NSCLC harboring dual ALK/ROS1 rearrangements, followed effectively by targeted therapy. It underscores the importance of high-precision molecular profiling to guide sequential treatment strategies. Although tyrosine kinase inhibitors remain the cornerstone for ALK- or ROS1-positive NSCLC, the ideal initial approach for concurrent ALK/ROS1 fusions is yet to be established. Unless there are studies with large cohorts clarifying the case, an individualized regimen-potentially starting with chemotherapy and transitioning to targeted agents-may be justified. Further clinical experience and collaborative research are essential to develop evidence-based guidelines for this exceptionally rare subset.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"120"},"PeriodicalIF":0.7,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jejunal leiomyosarcoma leading to intestinal intussusception: a case report. 空肠平滑肌肉瘤致肠套叠1例。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI: 10.21037/acr-2025-95
Qiongying Chen, Hongping Yuan, Ke Zhou

Background: Leiomyosarcoma (LMS) is a rare form of malignant tumor affecting the small intestine, specifically the jejunum. It can cause intussusception, a condition wherein one segment of the intestine telescopes into another, leading to obstruction, ischemia, and necrosis. Small intestinal intussusception in adults is a rare clinical condition. The majority of affected individuals have pathological factors, such as tumors, polyps, diverticula, inflammation, or intestinal adhesions. Abdominal pain and bowel obstruction are the most common symptoms, but small bowel tumors are often not visible on endoscopy, making additional imaging essential for accurate diagnosis. Herein, we report the clinical presentation, diagnosis, and treatment of jejunal LMS-induced intussusception in an adult patient.

Case description: A 56-year-old female was first admitted to our hospital in June 2024 due to intermittent abdominal distension and pain with paroxysmal exacerbation, and her abdominal pain lasted for more than 10 days. There was no hematemesis or melena. Initial computed tomography (CT) scans showed no abnormalities, but subsequent imaging revealed a left mid-abdominal jejuno-jejunal intussusception. The histopathological and immunostaining findings indicated jejunal LMS without metastasis, and emergency laparotomy revealed an intestinal tumor at the intussusception site. The tumor was surgically resected, and postoperative follow-up is underway. To date, the patient remains well but has declined further recommended testing and therapy.

Conclusions: This case underscores the uncommon clinical presentation of LMS-induced intestinal intussusception in adults. Timely diagnosis and intervention are critical for improving survival outcomes in patients with LMS. Surgical resection remains the treatment of choice for eligible candidates.

背景:平滑肌肉瘤(LMS)是一种罕见的影响小肠,特别是空肠的恶性肿瘤。它可引起肠套叠,肠的一段向另一段扩张,导致梗阻、缺血和坏死。摘要成人小肠肠套叠是一种罕见的临床疾病。大多数受影响的个体有病理性因素,如肿瘤、息肉、憩室、炎症或肠粘连。腹痛和肠梗阻是最常见的症状,但小肠肿瘤通常在内镜下不可见,因此需要额外的影像学检查才能准确诊断。在此,我们报告一位成人患者空肠lms诱导的肠套叠的临床表现、诊断和治疗。病例描述:女性,56岁,因间歇性腹胀疼痛伴阵发性加重,于2024年6月首次入住我院,腹痛持续10余天。无呕血或黑黑。最初的计算机断层扫描(CT)未显示异常,但随后的成像显示左侧腹部中部空肠-空肠肠套叠。组织病理学和免疫染色结果显示空肠LMS无转移,紧急剖腹手术显示肠套叠部位有肠肿瘤。肿瘤已手术切除,术后随访正在进行中。迄今为止,患者状况良好,但拒绝进一步推荐的检测和治疗。结论:本病例强调了lms诱导的成人肠套叠的罕见临床表现。及时诊断和干预对于改善LMS患者的生存结果至关重要。手术切除仍然是符合条件的患者的治疗选择。
{"title":"Jejunal leiomyosarcoma leading to intestinal intussusception: a case report.","authors":"Qiongying Chen, Hongping Yuan, Ke Zhou","doi":"10.21037/acr-2025-95","DOIUrl":"10.21037/acr-2025-95","url":null,"abstract":"<p><strong>Background: </strong>Leiomyosarcoma (LMS) is a rare form of malignant tumor affecting the small intestine, specifically the jejunum. It can cause intussusception, a condition wherein one segment of the intestine telescopes into another, leading to obstruction, ischemia, and necrosis. Small intestinal intussusception in adults is a rare clinical condition. The majority of affected individuals have pathological factors, such as tumors, polyps, diverticula, inflammation, or intestinal adhesions. Abdominal pain and bowel obstruction are the most common symptoms, but small bowel tumors are often not visible on endoscopy, making additional imaging essential for accurate diagnosis. Herein, we report the clinical presentation, diagnosis, and treatment of jejunal LMS-induced intussusception in an adult patient.</p><p><strong>Case description: </strong>A 56-year-old female was first admitted to our hospital in June 2024 due to intermittent abdominal distension and pain with paroxysmal exacerbation, and her abdominal pain lasted for more than 10 days. There was no hematemesis or melena. Initial computed tomography (CT) scans showed no abnormalities, but subsequent imaging revealed a left mid-abdominal jejuno-jejunal intussusception. The histopathological and immunostaining findings indicated jejunal LMS without metastasis, and emergency laparotomy revealed an intestinal tumor at the intussusception site. The tumor was surgically resected, and postoperative follow-up is underway. To date, the patient remains well but has declined further recommended testing and therapy.</p><p><strong>Conclusions: </strong>This case underscores the uncommon clinical presentation of LMS-induced intestinal intussusception in adults. Timely diagnosis and intervention are critical for improving survival outcomes in patients with LMS. Surgical resection remains the treatment of choice for eligible candidates.</p>","PeriodicalId":29752,"journal":{"name":"AME Case Reports","volume":"9 ","pages":"117"},"PeriodicalIF":0.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AME Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1